Physicochemical and Functional Characterization of a Biosimilar Adalimumab ZRC-3197

Biosimilars
doi 10.2147/bs.s75573
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

A Budget Impact Analysis of Adalimumab Biosimilar: The Italian Context

AboutOpen
2019English

Physicochemical Characterization and Phase I Study of CMAB008, an Infliximab Biosimilar Produced by a Different Expression System

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2019English

Assessing Analytical Similarity of Proposed Amgen Biosimilar ABP 501 to Adalimumab

BioDrugs
MedicineBiotechnologyPharmacology
2016English

Case Study: Biosimilar Anti TNFalpha (Adalimumab) Analysis of Fc Effector Functions

BMC Proceedings
BiochemistryMedicineGeneticsMolecular Biology
2013English

Physicochemical Characterization and Functional Site Analysis of Lactoferrin Gene of Vechur Cow

Bioinformation
2011English

A Review of the Totality of Evidence Supporting the Development of the First Adalimumab Biosimilar ABP 501

Advances in Therapy
MedicinePharmacology
2019English

OP0021 Efficacy and Safety Results of a Phase Iii Study Comparing Fkb327, an Adalimumab Biosimilar, With the Adalimumab Reference Product in Patients With Active Rheumatoid Arthritis

2017English

AB0954 a Randomised, Double-Blind Trial Comparing the Efficacy, Safety and Immunogenicity of Msb11022, a Proposed Biosimilar of Adalimumab, Versus Adalimumab Originator in Patients With Moderate-To-Severe Plaque Psoriasis

2018English

Safety of Adalimumab Biosimilar MSB11022 (Acetate-Buffered Formulation) in Patients With Moderately-To-Severely Active Rheumatoid Arthritis

Clinical Rheumatology
MedicineRheumatology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy